$VOR Cashflow Statement | Understand Stock

$VOR

$19.54 +$1.21 (6.6%) Close

$VOR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operations:
Depreciation expense
Non-cash lease expense
Stock-based compensation
Other
Transaction costs for issuance of pre-funded warrants
Change in fair value of warrant liabilities
Interest amortization on marketable securities
Loss (gain) on sale of property and equipment
Issuance of pre-funded warrants in connection with the acquisition of in-process research and development
Changes in operating assets and liabilities:
Operating lease liabilities
Prepaid expenses and other current assets
Accounts payable and accrued liabilities
Other assets

Net cash used in operating activities
Cash flow from investing activities
Purchases of investments
Purchases of marketable securities
Proceeds from maturities of marketable securities
Purchases of property and equipment
Proceeds from sales of property and equipment
Net cash (used in) provided by investing activities

Cash flow from financing activities
Proceeds from issuance of redeemable convertible preferred stock
Proceeds from the issuance of common stock upon closing of initial public offering, net of underwriter fees
Payment of initial public offering costs
Proceeds from stock option exercises
Proceeds from the issuance of common stock from public offering and concurrent private placement, net of underwriter fees and issuance costs
Payment of issuance costs related to underwritten public offering and concurrent private placement
Proceeds from the issuance of common stock from private placement
Proceeds from the issuance of common stock from underwritten public offering, net of underwriting discount and commissions
Proceeds from the issuance of pre-funded warrants
Payment of issuance costs related to underwritten public offering and private placements
Proceeds from the issuance of common stock from at-the-market sales agreement, net of issuance costs
Proceeds from stock option exercises and issuance of common stock under ESPP
Withholding of shares for tax withholdings upon vesting of restricted stock unit awards
Proceeds from stock option exercises and the issuance of shares under ESPP
Net cash provided by financing activities

Net increase in cash, cash equivalents and restricted cash equivalents
Cash, cash equivalents and restricted cash equivalents, beginning of period
Cash, cash equivalents and restricted cash equivalents, end of period
Supplemental disclosure of non-cash activities
Lease incentive paid by the landlord on behalf of the Company
Right-of-use assets obtained in exchange for lease obligations
Purchases of property and equipment in accounts payable and accrued liabilities
Financing costs associated with the sale of common stock included in accounts payable and accrued expenses
Conversion of redeemable convertible preferred stock to common stock upon closing of the initial public offering
Unrealized gain on available-for-sale securities
Issuance of pre-funded warrants in connection with the acquisition of in-process research and development

Comments